If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Omvoh ™ (mirikizumab-mrkz) injection
300 mg/15 mL, 100 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What if a patient only uses 1 pen (instead of the required 2 pens) for a maintenance dose of Omvoh™ (mirikizumab-mrkz)?
If a dose of Omvoh (mirikizumab) is missed, administer the dose as soon as possible. Thereafter, resume dosing every 4 weeks.
Additional Information
Recommendations on How to Proceed With Dosing if Only One Pen Was Injected provides recommendations for what to do in the event a patient only injects 1 pen for their maintenance dose (instead of 2 pens which make up a full maintenance dose).1
If only one pen was injected and it has been... |
Then it is recommended that the patient |
less than 4 weeks since the last injection |
inject the missed pen as soon as possible and continue every 4-week maintenance dosing.1 |
4 weeks or more since the last injection |
skip the missed pen and resume scheduled maintenance dosing with 2 pens every 4 weeks.1 |
What if the Patient Has Only Injected 1 Pen for a Single Past Maintenance Dose?
The patient should resume scheduled maintenance dosing with 2 pens every 4 weeks.1
Enclosed Prescribing Information
References
1Omvoh [package insert]. Indianapolis, IN: Eli Lilly and Company; 2023.
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: May 30, 2023